生物医药行业创新物流解决方案提供商Cellbox Solutions筹集了350万欧元A轮融资-动脉网

Cellbox raises €3.5 million for warm-chain logistics of living cells

D-Pharm 等信源发布 2026-03-09 13:54



可切换为仅中文







Cellbox Solutions announced the first closing of its

Cellbox Solutions宣布了其首次收盘

Series A financing

A轮融资

round, raising approximately EUR 3.5 million. The round is led by the digital business angel network Companisto, together with existing investors, including NRW.BANK. The new capital will be used to expand international production and sales activities and to unlock additional application areas, particularly in cell and .

一轮融资，筹集了大约350万欧元。此轮融资由数字商业天使网络Companisto领投，现有投资者包括NRW.BANK。新资金将用于扩大国际生产和销售活动，并开拓更多的应用领域，特别是在细胞和。

gene therapy

基因治疗

as well as in vitro fertilization (IVF). In addition, the management team is strategically strengthened with the appointment of Dr. Bernd Muehlenweg to further drive growth and scalability. This is the first closing of a Series A financing round which remains open for other tranches until May 2026.

以及体外受精（IVF）。此外，管理团队通过任命Bernd Muehlenweg博士进一步推动增长和可扩展性，得到了战略性加强。这是A轮融资的首次交割，本轮融资本轮将持续开放至2026年5月以接纳其他批次。

。

Cellbox™ develops portable CO₂

Cellbox™ 开发便携式二氧化碳设备

incubators

孵化器

for the safe transport of living cell samples. Its patented warm-chain technology enables continuously controlled shipment conditions for up to 48 hours, preserving cell viability and functionality during transport. The systems are certified and compliant with IATA regulations for air transport. More than 300 devices are already in use worldwide by leading customers in the pharmaceutical and biotechnology industries, applied research institutions, and universities.

为了活细胞样本的安全运输。其获得专利的温链技术能够实现长达48小时的持续可控运输条件，确保细胞在运输过程中的存活率和功能性。该系统经过认证，符合国际航空运输协会（IATA）的空运规定。目前，全球已有300多台设备被制药和生物技术行业的领先客户、应用研究机构以及大学使用。

。

A key component of this next growth phase is the appointment of Dr. Bernd Muehlenweg as Chief Business Officer (CBO) and Chief Financial Officer (CFO) of Cellbox™. He joins the company full-time with more than 20 years of international experience in the life sciences industry. Most recently, Dr. Muehlenweg served as Senior Vice President and Global Head of Business Development, Cell Therapy at Evotec, where he led international commercial and strategic partnership activities in the advanced therapy space..

这一增长阶段的关键组成部分是任命 Bernd Muehlenweg 博士为 Cellbox™ 的首席业务官 (CBO) 和首席财务官 (CFO)。他全职加入公司，带来了超过 20 年的国际生命科学行业经验。最近，Muehlenweg 博士曾担任 Evotec 的高级副总裁兼细胞治疗全球业务发展主管，领导了先进治疗领域的国际商业和战略合作伙伴活动。

“Cellbox™ is setting a new benchmark in the

“Cellbox™ 正在树立新的标杆在

transportation

运输

of living cells. By enabling safe, controlled, and reproducible transport under physiological conditions, we address a critical bottleneck in the life sciences industry. The investment round marks an important milestone in expanding our international footprint and establishing Cellbox™ as a global infrastructure standard for living cell shipment and warm-chain logistics.

活细胞。通过在生理条件下实现安全、可控且可重复的运输，我们解决了生命科学行业中的一个关键瓶颈。本轮投资标志着我们在扩大国际影响力并将Cellbox™确立为活细胞运输和温链物流的全球基础设施标准方面迈出了重要的一步。

Our patented platform and strong regulatory positioning provide an excellent foundation for global scale-up across multiple life sciences applications, including the rapidly growing field of cell and gene therapies. I look forward to further strengthening our commercial operations, expanding our service portfolio, and building the organizational structures required to support the next phase of international growth,” commented Dr.

我们的专利平台和强有力的监管定位为包括细胞和基因疗法在内的多个生命科学应用的全球扩展提供了坚实的基础。我期待进一步加强我们的商业运营，拓展服务组合，并建立支持下一阶段国际增长所需的组织结构，”博士评论道。

Bernd Muehlenweg, CBO & CFO of Cellbox Solutions GmbH..

贝恩德·穆伦韦格，Cellbox Solutions GmbH的首席商务官（CBO）兼首席财务官（CFO）。

Dr. Bernd Muehlenweg

伯恩德·穆勒内格博士

Cellbox Solutions GmbH

细胞盒解决方案有限公司

“Cellbox™ addresses a structural gap in the life sciences value chain: the reliable transport of living cells at physiological conditions. As advanced therapies scale globally, logistics becomes a critical success factor. We view Cellbox™ not as an incremental product innovation, but as a scalable platform with the potential to redefine how sensitive biological materials are transported across research and clinical environments,” added Dr.

“Cellbox™ 解决了生命科学价值链中的一个结构性缺口：在生理条件下可靠地运输活细胞。随着先进疗法在全球范围内的扩展，物流成为关键的成功因素。我们认为 Cellbox™ 不仅仅是一个渐进式的产品创新，而是一个可扩展的平台，有潜力重新定义敏感生物材料在研究和临床环境中的运输方式，”博士补充道。

Robin Ghosh, Investment Manager at Companisto..

罗宾·戈什，康帕尼托公司的投资经理。

Companisto will actively support Cellbox™ in its next growth phase. As a fully digitalized business angel network, Companisto contributes not only capital but also targeted strategic expertise to international scaling.

Companisto 将在 Cellbox™ 的下一个增长阶段积极提供支持。作为一家完全数字化的商业天使网络，Companisto 不仅提供资金，还为国际扩展贡献有针对性的战略专业知识。

“Our vision is to redefine how living cells are transported globally. With the continued support of our investors and the strengthening of our leadership team with a highly experienced executive, we are building the foundation for long-term international growth and expanding the reach of warm-chain logistics across clinical and research applications.

“我们的愿景是重新定义活细胞在全球范围内的运输方式。在投资者的持续支持下，并通过引入经验丰富的高管来加强我们的领导团队，我们正在为长期的国际增长奠定基础，并扩大温控物流在临床和研究领域的应用范围。”

We are convinced that reliable live-cell transport will become an essential component of the global life sciences value chain,” concluded Prof. Dr. Kathrin Adlkofer, Founder and CEO of Cellbox™..

“我们相信，可靠的活细胞运输将成为全球生命科学价值链的重要组成部分，”Cellbox™ 创始人兼首席执行官Kathrin Adlkofer教授总结道。

In the long term, Cellbox™ aims to establish warm-chain logistics as the preferred global approach for transporting living cells, cell therapies, and sensitive biological materials, further advancing reliability and reproducibility across the life sciences sector.

从长远来看，Cellbox™ 旨在建立温链物流，作为运输活细胞、细胞疗法和敏感生物材料的全球首选方法，进一步提高生命科学领域的可靠性和可重复性。

https://www.bionity.com/en/news/1188234/cellbox-raises-3-5-million-for-warm-chain-logistics-of-living-cells.html

Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities

查尔斯河实验室收购维真生物科学以增强基因治疗能力

Further Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy CDMO Sector

进一步扩展查尔斯河在高增长细胞和基因治疗CDMO领域的科学能力

Read news

阅读新闻